The scope of this procurement is to develop, refine, deploy, validate, maintain, and support a next-generation cloud-based electronic vision-related quality of life epro platform for use by NIH and…

Active Awarded Last action

Contract number
75N98125F00001
Awardee
Awarding agency
Obligated
$7,528,104

Award facts

Opportunity
  • C121294SB Solicitation number
Contract value 45% obligated
  • $7,528,104.27 Current, with exercised options
  • $16,799,827.19 Potential, with all options
Completion date 22% complete
  • Current, with exercised options
  • Potential, with all options
Funding agency
National Eye Institute National Institutes of Health, Department of Health and Human Services
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 · NEI electronic patient reported outcome platform (epro) - ption year 1 $3,723,349
Original award $3,804,755

About this award

The National Eye Institute issued a delivery order to Digital Infuzion, LLC on September 29, 2025, under the CIO-SP3 SB GWAC for development, refinement, deployment, validation, maintenance, and support of a next-generation cloud-based electronic vision-related quality of life ePRO platform for use by NIH and its partners. The order carries a ceiling value of $16.8 million and is set aside for Total Small Business. Digital Infuzion is a minority-owned and Subcontinent Asian American-owned small business based in Rockville, Maryland.

Place of performance is North Bethesda, MD. The order runs through September 28, 2030, under firm fixed-price terms. As of FY2025 Service Contract Inventory reporting, the order has not yet generated invoiced labor activity; no FTEs or subcontractors were reported in the most recent fiscal year.

Description

The scope of this procurement is to develop, refine, deploy, validate, maintain, and support a next-generation cloud-based electronic vision-related quality of life epro platform for use by NIH and its partners that aligns with current best practices

Quick answers

Who was awarded contract 75N98125F00001?

75N98125F00001 was awarded to Digital Infuzion, LLC by NITAAC Office of Information Technology Acquisition (National Institutes of Health) on September 29, 2025.

How much is contract 75N98125F00001 worth?

The government has obligated $7,528,104 on 75N98125F00001. Its potential value, with all options, is $16,799,827.

Which agency awarded contract 75N98125F00001?

NITAAC Office of Information Technology Acquisition (National Institutes of Health) awarded 75N98125F00001, with funding from National Eye Institute (National Institutes of Health).

Is contract 75N98125F00001 an order under another contract?

Yes. 75N98125F00001 is a delivery order under HHSN316201200128W, a government wide acquisition contract (GWAC), on Chief Information Officer - Solutions and Partners 3, Small Business (CIO-SP3 SB).

Was contract 75N98125F00001 competed?

The extent of competition for 75N98125F00001 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award